-
-
Toggle navigation
Impact Factor 4.137 | CiteScore 4.28
More on impact ›
in Oncology |
|
Submit your manuscript
Scope
The section is aptly named, as the field of radiation oncology is currently entering a new frontier of more personalized cancer treatment. We are being led into this new frontier by the explosion of information in cancer biology; the maturation of 3-dimensional (3-D) to 4- dimensional (4-D) photon and proton radiation planning and delivery; the refinement of more sensitive tumor-imaging technologies for radiation therapy targeting; and a better understanding of how best to integrate radiation therapy with conventional chemotherapy, newer biologics, as well as surgery, in a multi-modality approach. As such, we aim to publish notable basic and clinical research relating to all aspects of radiation oncology. Specifically, we welcome papers on the following topics: 1) identification and characterization of genetic and epigenetic alterations affecting biological signaling networks involved in radiation damage and repair processing in normal and malignant cells/tissues; 2) development and testing of 3-D and 4- D radiation treatment delivery systems and/or novel tumor-imaging technologies that impact radiation delivery, treatment response, or morbidities of treatment; 3) development and pre- clinical/clinical testing of novel radiation modifying drugs and small molecules; and 4) integration of systems biology approaches including the development of mathematical and computational models to better bridge the translation from basic to clinical radiation oncology research.Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Radiation Oncology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Radiation Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Radiation Oncology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Oncology.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact oncology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact oncology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org